The FDA has approved Lipfendra, the first oral PCSK9 inhibitor, for the treatment of high cholesterol. Two medical experts explain why this matters.
High cholesterol is one of the major risk factors for heart disease and stroke. While statins have been the most common ...
An IFIC survey found 7 percent of U.S. adults were following this particular diet in 2022.
US regulators approved a first-of-its kind pill from Merck that is designed to help lower cholesterol levels beyond what ...
ABP News on MSN
Heart Surgeon Shares 5 Simple Habits That Could Help Prevent A Heart Attack In 60 Seconds
Although many of the risk factors can be recognised and addressed long before an emergency arises, heart attacks frequently ...
The Food and Drug Administration has approved a powerful new kind of cholesterol-lowering drug.
India Today on MSN
FDA clears first daily pill that could change bad cholesterol treatment
The USFDA has approved Lipfendra, the first oral PCSK9 inhibitor, for lowering LDL cholesterol. The once-daily pill could improve long-term adherence, though Indian access will depend on approval and ...
Getting to sleep before midnight is a rarity, as is waking up before 9.30am. Like many night owls, Wagner skips breakfast, ...
Clinical trials have shown that Lipfendra can bring levels of LDL, the bad type of cholesterol, down 60%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results